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Leinamycin (LNM), produced by Streptomyces atroolivaceus, is a thiazole-containing hybrid peptide-
polyketide natural product structurally characterized with an unprecedented 1,3-dioxo-1,2-dithiolane moiety
that is spiro-fused to a 18-member macrolactam ring. LNM exhibits a broad spectrum of antimicrobial and
antitumor activities, most signiﬁcantly against tumors that are resistant to clinically important anticancer
drugs, resulting from its DNA cleavage activity in the presence of a reducing agent. Using a PCR approach to
clone a thiazole-forming nonribosomal peptide synthetase (NRPS) as a probe, we localized a 172-kb DNA
region from S. atroolivaceus S-140 that harbors the lnm biosynthetic gene cluster. Sequence analysis of 11-kb
DNA revealed three genes, lnmG, lnmH, and lnmI, and the deduced product of lnmI is characterized by domains
characteristic to both NRPS and polyketide synthase (PKS). The involvement of the cloned gene cluster in
LNM biosynthesis was conﬁrmed by disrupting the lnmI gene to generate non-LNM-producing mutants and by
characterizing LnmI as a hybrid NRPS-PKS megasynthetase, the NRPS module of which speciﬁes for L-Cys
and catalyzes thiazole formation. These results have now set the stage for full investigations of LNM biosyn-
thesis and for generation of novel LNM analogs by combinatorial biosynthesis.
The ﬁve-member heterocycles of thiazole or oxazole or their
reduced structures of thiazoline and thiazolidine or oxazoline
and oxazolidine are signature pharmacophores common to
many clinically important natural products (44), such as baci-
tracin (26) and pristinamycin IIB (4) (antibacterial) and bleo-
mycin (12) and epothilone (35, 49) (anticancer) (Fig. 1A).
They are also common structural motifs for many microbial
pathogenesis factors (10), such as pyochelin from Pseudomo-
nas aeruginosa (9, 39), vibriobactin from Vibrio cholerae (23,
52), yersiniabactin from Yersinia pestis (17, 40), mycobactin
from Mycobacterium tuberculosis (41), and microcin B17 from
Escherichia coli (24, 29) (Fig. 1B).
Biosynthetically these heterocycles result from cyclization
(Cy) of the cysteine (Cys), serine, or threonine side chain onto
the proceeding carbonyl group of the peptide substrates, and
two mechanisms are known for this process. One is exempliﬁed
by the maturation of microcin B17, where the heterocycle-
forming steps occur posttranslationally, catalyzed by the mic-
rocin B17 synthetase (29). The other is observed for nonribo-
somal peptide biosynthesis where the peptide elongation and
heterocycle-forming steps proceed processively, catalyzed by
nonribosomal peptide synthetases (NRPS). The latter enzymes
are characterized by unique catalytic domains, such as the Cy,
oxidization (Ox), and reduction domains, which act on the
nascent peptidyl-S-NRPS intermediate to furnish the hetero-
cycles into the resultant natural products (11, 27, 44, 51).
Leinamycin (LNM) is a novel thiazole-containing natural
product produced by several Streptomyces atroolivaceus species
(18, 20, 36). Its structure was established by spectroscopic (18,
20) and X-ray crystallographic analyses (21) and was conﬁrmed
by total synthesis (15, 22). LNM is characterized by an unusual
1,3-dioxo-1,2-dithiolane moiety that is spiro-fused to a 18-
member macrolactam ring, a molecular architecture that has
not been found to date in any other natural product (Fig. 1C).
LNM exhibits a broad spectrum of antimicrobial activity
against gram-positive and gram-negative bacteria but not
against fungi. It shows potent antitumor activity in murine
tumor models in vivo, most signiﬁcantly against tumors that are
resistant to clinically important anticancer drugs, such as cis-
platin, doxorubicin, mitomycin, and cyclophosphamide (18,
36). LNM preferentially inhibits DNA synthesis, resulting in
interference with the growth of susceptible cells. It alkylates
DNA to cause single-strand scission of DNA in the presence of
a thiol as a reducing cofactor, and the presence of a sulfoxide
group in the dithiolane moiety is essential for the DNA cleav-
age activity (19). Although simple 1,3-dioxo-1,2-dithiolanes
are also thiol-dependent DNA cleavage agents in vitro (16,
34), the mechanisms for DNA cleavage by simple 1,3-dioxo-
1,2-dithiolanes and LNM are distinct—oxidative cleavage by
the former mediated by DNA-cleaving oxygen radicals and
alkylative cleavage by the latter mediated by an episulfonium
ion intermediate (1, 5, 19).
The biosynthetic origin of LNM has not been established by
in vivo isotope-labeling experiment. The structural similarity of
LNM to macrolides in general and to thiazole-containing hy-
brid peptide-polyketide metabolites, such as bleomycin (12)
and epothilone (35, 49), in particular, however, supports the
hypothesis that it is of hybrid peptide-polyketide origin. Thus,
on the basis of the emerging paradigm for hybrid peptide-
polyketide biosynthesis (6, 7, 13), we postulated that a hybrid
NRPS-polyketide synthase (PKS) system would be responsible
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7013for the biosynthesis of the 18-member LNM macrolactam ring
and that an NRPS module characterized by a Cys-speciﬁc
adenylation (A) domain and the thiazole-forming Cy and Ox
domains would speciﬁcally furnish the thiazole moiety of
LNM. We set to clone this NRPS gene by a PCR approach as
the starting point toward cloning the entire lnm biosynthetic
gene cluster. The availability of the lnm gene cluster should
greatly aid our effort to investigate LNM biosynthesis and to
produce novel LNM analogs for anticancer drug development
by manipulation of genes governing LNM biosynthesis. Here
we report the ampliﬁcation of a Cy domain sequence from the
genome of an LNM-producing S. atroolivaceus strain S-140 by
PCR, the cloning and characterization of a thiazole-forming
NRPS module and conﬁrmation of this NRPS module in LNM
FIG. 1. Examples of ﬁve-member, heterocycle (boxed)-containing, natural products: antibiotics (A), pathogenesis factors (B), and leinamycin
(C).
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of the entire lnm biosynthetic gene cluster.
MATERIALS AND METHODS
Bacterial strains and plasmids. E. coli DH5 (45), E. coli XL1-Blue MRF’
(Stratagene, La Jolla, Calif.), E. coli S17-1 (25), and E. coli BL21(DE3) (Nova-
gen, Madison, Wis.) were used in this work. Vectors pGEM-T, pGEM-5zf,
pGEM-9zf (Promega, Madison, Wis.), pBluescript II SK (Stratagene), and pET-
37b (Novagen) were from commercial sources, and pOJ260, pKC1139, and
pOJ446 were described previously (3). The S. atroolivaceus strains and other
plasmids used in this study are listed in Table 1.
Biochemicals, chemicals, and media. LNM standard was a gift from Kyowa
Hakko Kogyo Co. Ltd. (Tokyo, Japan). Unless speciﬁed otherwise, other com-
mon biochemicals and chemicals were from standard commercial sources. E. coli
strains carrying plasmids were grown in Luria-Bertani (LB) medium and were
selected with appropriate antibiotics (45). All media for Streptomyces growth
were prepared according to standard protocols (25). DNB, ISP-2, ISP-4, and
tryptic soy broth (TSB) were from Difco Laboratories (Detroit, Mich.), and
modiﬁed ISP-4 is ISP-4 supplemented with 0.05% yeast extract and 0.1% tryp-
tone (30).
DNA isolation, manipulation, and sequencing. Plasmid preparation and DNA
extraction were carried out by using commercial kits (Qiagen, Valencia, Calif.).
Total S. atroolivaceus DNA was isolated according to protocols from the litera-
ture (25, 42). Restriction endonuclease digestion and ligation were done by
standard methods (45). For Southern analysis, digoxigenin labeling of DNA
probes, hybridization, and detection were performed according to the protocols
provided by the manufacturer (Boehringer Mannheim Biochemicals, Indianap-
olis, Ind.). Automated DNA sequencing was carried out on an ABI Prism 377
DNA sequencer (Perkin-Elmer/ABI, Foster City, Calif.), and this service was
provided by Davis Sequencing Inc. (Davis, Calif.). Data were analyzed by the
ABI Prism Sequencing 2.1.1 software and the Genetics Computer Group pro-
gram (Madison, Wis.).
PCR. PCR primers for Cy (Cy-FP and Cy-RP) and Ox (Ox-FP and Ox-RP)
domain ampliﬁcation (Fig. 2) were designed by using the COnsensus-DEgener-
ate Hybrid Oligonucleotide Primer (CODEHOP) strategy of PCR primer design
(43). They were synthesized at the Macromolecular Structure Facility, University
of California, Davis. PCRs were performed on a GeneAmp 2400 thermocycler
(Perkin-Elmer/ABI). A typical PCR (50 l) consists of 1.5 mM MgCl2,5n go fS.
atroolivaceus genomic or cosmid DNA as the template, 7.5% dimethyl sulfoxide,
100 M deoxynucleoside triphosphates, 25 pmol of each primer, and 2.5 U of
Taq DNA polymerase in 1 PCR buffer. For Cy domain ampliﬁcation, the
program was as follows: prerun denaturation at 95°C for 3 min, followed by 10
cycles of ramp ampliﬁcation (45 s at 94°C, 1 min of annealing with ramping from
65 to 55°C, and 1.5 min at 72°C), then 25 cycles of ampliﬁcation with a constant
annealing temperature of 55°C, and ﬁnally postrun extension for 10 min at 72°C.
A distinctive product with the predicted size of 1.1 kb was obtained with the
FIG. 2. The conserved core motifs and PCR primers designed for
them according to the CODEHOP strategy: Cy domain (A) and Ox
domain (B). Protein accession numbers (GenBank) are given in pa-
rentheses: BacA (O68006), BlmIII (AAG02365), BlmIV (AAG02364),
EposP (AAF26925), HMWP2 (P48633), MtaC (AAF19811), MtaD
(AAF19812), and PchE (AAD55800). The numbers between the
motifs indicate the distance in amino acids (aa). K, G/T; M, A/C; N,
G/A/T/C; R, A/G; S, C/G; and Y, C/T.
TABLE 1. Bacterial strains and plasmids used in the study
Strain or plasmid Description Source or
reference
S. atroolivaceus strains
S-140 Wild-type, LNM producing 18
SB3001 lnmI-disrupted mutant resulted from homologous integration of pBS3012 into the S-140 strain;
Apr, non-LNM producing
This work
Plasmids
pBS3001 1.1-kb PCR product from S. atroolivaceus S-140 with Cy-FP and Cy-RP primers in pGEM-T This work
pBS3002 0.3-kb PCR product from S. atroolivaceus S-140 with Ox-FP and Ox-RP primers in pGEM-T This work
pBS3003 5.2-kb PCR product from S. atroolivaceus S-140 with Cy-FP and Ox-RP primers in pGEM-T This work
pBS3004 pOJ446-derived S. atroolivaceus S-140 genomic library cosmid This work
pBS3005 pOJ446-derived S. atroolivaceus S-140 genomic library cosmid This work
pBS3006 pOJ446-derived S. atroolivaceus S-140 genomic library cosmid This work
pBS3007 pOJ446-derived S. atroolivaceus S-140 genomic library cosmid This work
pBS3008 pOJ446-derived S. atroolivaceus S-140 genomic library cosmid This work
pBS3009 4.6-kb NcoI fragment from pBS3006 into the same site of pGEM-5zf This work
pBS3010 2.8-kb NcoI fragment from pBS3006 into the same site of pGEM-5zf This work
pBS3011 5.1-kb BamHI fragment from pBS3006 into the same site of pBluescript II SK This work
pBS3012 1.1-kb EcoRI fragment from pBS3001 into the same site of pOJ260 This work
pBS3013 1.1-kb EcoRI fragment from pBS3001 into the same site of pKC1139 This work
pBS3014 PCR-ampliﬁed 5 end (a 372-bp EcoRI-SpeI fragment) and 3 end (a 293-bp SpeI-HindIII fragment)
of lnmI (A-PCP) into the EcoRI and HindIII sites of pSP72
This work
pBS3015 1.2-kb NcoI-BamHI internal fragment of lnmI (A-PCP) from pBS3010 into the same sites of pBS3014 This work
pBS3016 1.9-kb NdeI-HindIII fragment of lnmI (A-PCP) from pBS3015 into the same sites of pET-37b This work
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pBS3001. For Ox domain ampliﬁcation, the program was the same except that
the ramp temperature was from 60 to 50°C and that the extension time was 45 s.
With the Ox-FP and Ox-RP pair of primers, no product was ampliﬁed from S.
atroolivaceus genomic DNA but a distinctive product with the predicted size of
0.3 kb was ampliﬁed from several Cy-containing cosmid clones. This product was
subsequently cloned in pGEM-T to yield BS3002. For ampliﬁcation of the entire
NRPS module, the PCR program was the same as for Cy domain ampliﬁcation
except that extension time was 5 min. With the Cy-FP and Ox-RP pair of primers,
a distinctive product of 5.2 kb was ampliﬁed from S. atroolivaceus cosmid library
DNA and cloned in pGEM-T to afford pBS3003.
S. atroolivaceus genomic library construction and screening. A genomic library
of S. atroolivaceus S-140 was constructed in the pOJ446 cosmid according to
protocols from the literature (25, 42). Gigapack III XL packaging extract (Strat-
agene) was used for library construction according to the manufacturer’s instruc-
tions. The titer of the primary library was approximately 2.2  10
5 PFU per g
of DNA. The primary library was ampliﬁed once; aliquots of it were stored at
80°C. The titer for the ampliﬁed library was approximately 2  10
5 CFU/l.
To screen the genomic library, cosmid clones from four plates (with approx-
imately 1,000 colonies per plate) were transferred to Immobilon-Ny
 nylon
membranes (Millipore Corp., Bedford, Mass.) and were hybridized with the
digoxigenin-labeled 1.1-kb EcoRI fragment of the Cy domain from pBS3001 as
a probe (Fig. 3A, Probe-1). Resultant positive cosmid clones were rescreened by
PCR with primers speciﬁc for Cy (Cy-FP and Cy-RP), Ox (Ox-FP and Ox-RP),
and the thiazole-forming NRPS module (Cy-FP and Ox-RP) and were conﬁrmed
by Southern hybridization. Further restriction endonuclease mapping of and
chromosomal walking from these overlapping cosmids lead to the genetic local-
ization of a 172-kb contiguous DNA region, as represented by pBS3004,
pBS3005, pBS3006, pBS3007, and pBS3008 (Fig. 3A). A total of 11 kb of DNA
from pBS3006 that hybridized to the PCR-ampliﬁed NRPS fragment from
pBS3003 was subcloned as three overlapping clones: a 4.6-kb NcoI fragment into
pGEM-5zf to yield pBS3009, a 2.8-kb NcoI fragment into pGEM-5zf to yield
pBS3010, and a 5.1-kb BamHI fragment into pBluescript II SK to yield pBS3011;
their DNA sequences were subsequently determined.
Construction of the lnmI mutant by gene disruption. The 1.1-kb internal
fragment of lnmI ampliﬁed by PCR with the Cy-FP and Cy-RP pair of primers
was cloned as an EcoRI fragment from pBS3001 into the same site of pOJ260
and pKC1139 to yield pBS3012 and pBS3013, respectively. Introduction of
pBS3012 and pBS3013 into S. atroolivaceus S-140 was carried out by conjugation,
following a procedure from the literature (30) with minor modiﬁcations. In brief,
S. atroolivaceus S-140 spores were heat shocked in TSB medium at 42°C for 20
min, followed by incubation at 30°C for up to 6 h. Spore germination was
monitored microscopically every 30 min after4ho fincubation at 30°C. Germi-
nated spores were pelleted and resuspended in LB medium as S. atroolivaceus
recipients. E. coli S17-1(pBS3012) or E. coli S17-1(pBS3013) was grown in LB
medium with appropriate antibiotics for selection to cell density of 0.3 to 0.4 at
600 nm. Cells from 2-ml culture were pelleted, washed with LB medium, and
resuspended in 100 l of LB medium as the E. coli donors. For conjugation, the
donors (100 l) and recipients (100 l, 10
8 spores) were mixed and spread onto
a modiﬁed ISP-4 plate freshly supplemented with 10 mM MgCl2. The plates were
incubated at 28°C for 16 to 22 h. After removal of most of the E. coli S17-1
donors from the plates by washing the surface with sterile water, each plate was
overlaid with 3 ml of soft LB medium (0.7% agar) containing apramycin (Apr)
at a ﬁnal concentration of 50 g/ml and nalidixic acid at a ﬁnal concentration of
50 g/ml. Incubation continued at 28°C until exconjugants appeared (in about a
week).
Production, isolation, and analysis of LNM. S. atroolivaceus strains were
fermented under conditions taken from the literature (18, 20) with modiﬁcations.
In brief, the seed medium (25 ml in a 250-ml bafﬂed ﬂask), consisting of 10 g of
glucose, 10 g of soluble starch,3go fbeef extract,5go fyeast extract,5go f
Bacto-Tryptone, and2go fCaCO3 per liter, pH 7.2, was inoculated with 10 l
of spore suspension and incubated at 25°C, 250 rpm, for 48 h. The resultant seed
inoculum (5 ml) was then used to inoculate the production medium (50 ml in a
250-ml bafﬂed ﬂask), consisting of 40 g of soluble starch,5go fsoybean meal,
2.5 g of corn steep liquor, 0.5 g of KH2PO4, 0.25 g of MgSO4,4 0m go f
ZnSO4  7H2O, 0.1 g of methionine, 0.1 mg of vitamin B12,a n d5go fCaCO3 per
liter, pH 7.0. The production culture was fermented at 28°C, 250 rpm, for 72 h.
Sterile, moisturized Diaion HP-20 resins (5% [wt/vol]) (Supelco, Bellefonte, Pa.)
were added to the production culture 18 h after inoculation. For LNM isolation,
the production culture was acidiﬁed to pH 2 with H2SO4. The HP-20 resins were
recovered by ﬁltration through two layers of cheesecloth and were then lyophi-
lized to dryness. Crude LNM was eluted off the HP-20 resins with methanol (10
resin volumes), and the methanol elute was concentrated in vacuo. High-perfor-
mance liquid chromatography (HPLC) analysis of LNM was achieved through a
two-step procedure with a Microsorb-MV C18 column (5 M, 100 A ˚, 4.6 mm by
25 cm; Varian, Walnut Creek, Calif.) on a ProStar-210 HPLC system with a
PDA-330 UV-VIS detector at 320 nm (Varian). In the ﬁrst step, partially pure
LNM was collected upon isocratic elution with 50% methanol in 25 mM
KH2PO4, pH 4.0, at a ﬂow rate of 0.6 ml/min. In the second step, the partially
puriﬁed LNM was baseline resolved by a linear gradient elution from 20 to 80%
acetonitrile in 10 mM KH2PO4, pH 4.0, in 30 min at a ﬂow rate of 0.6 ml/min.
The identity of LNM was conﬁrmed by coelution with authentic LNM standard
and electrospray ionization-mass spectrometry (ESI-MS) analysis. The latter was
performed on an LCQ-Decca mass spectrometer (ThermoQuest, San Jose, Cal-
if.) at the Molecular Structure Facility, University of California, Davis.
Overexpression of lnmI (A-peptidyl carrier protein [PCP]) in E. coli and
puriﬁcation of the LnmI (A-PCP) protein. The 5 end of lnmI (A-PCP) was
ampliﬁed from pBS3006 by PCR using a forward primer of 5-G GAA TTC C
FIG. 3. (A) A 172-kb DNA region from S. atroolivaceus S-140 harboring the lnm biosynthetic gene cluster as represented by ﬁve overlapping
cosmid clones. Probes used to clone and map the lnm gene cluster were marked. (B) Genetic organization of the lnmG, lnmH, and lnmI genes and
domain organization of the LnmI hybrid NRPS-PKS protein. Cy, condensation/cyclization. A, adenylation; KS, ketoacyl synthase; B, BamHI; N,
NcoI.
7016 CHENG ET AL. J. BACTERIOL.AT ATG GAG CTG CAC AAG ATC CTG CAC-3 (both EcoRI and NdeI sites
are underlined) and a reverse primer of 5-CC ACT AGT GCG CCT CCT CGA
GGA TGA C-3 (the SpeI site is underlined) as a 372-bp fragment. The 3 end
of lnmI (A-PCP) was ampliﬁed from pBS3006 by PCR using a forward primer of
5-GG ACT AGT CGC GCG ACG AGC TGT GCG-3 (the SpeI site is under-
lined) and a reverse primer of 5-CG CGC AAG CTT CGC GGT CTC CGC
CTC GGC GGC-3 (the HindIII site is underlined) as a 293-bp fragment. These
two fragments were digested with EcoRI-SpeI and SpeI-HindIII, respectively,
and were cloned together into the EcoRI-HindIII sites of pSP72 to afford
pBS3014. The 1.2-kb NcoI-BamHI internal fragment of lnmI (A-PCP) from
pBS3010 was then cloned into the same sites of pBS3014 to yield pBS3015. DNA
sequencing conﬁrmed that pBS3015 contains the complete lnmI (A-PCP) se-
quence. The lnmI (A-PCP) fragment was ﬁnally moved as a 1.9-kb NdeI-HindIII
fragment from pBS3015 into the same sites of pET-37b to yield the expression
construct pBS3016. Introduction of pBS3016 into E. coli BL21(DE3) under
standard conditions resulted in the production of LnmI (A-PCP) as a C-terminal
His8-tagged fusion protein. To improve the solubility, the incubation tempera-
ture was lowered to 25°C with 0.1 mM isopropyl--D-thiogalactopyranoside
(IPTG) induction for4ha t2 5 0rpm. The soluble fraction of LnmI (A-PCP) was
subsequently puriﬁed by afﬁnity chromatography on Ni-nitrilotriacetic acid resin
according to the manufacturer’s protocols (Qiagen). Puriﬁcation was monitored
by sodium polyacrylamide gel electrophoresis (SDS-PAGE), and the yield of the
puriﬁed protein was 92 mg/liter. The puriﬁed protein was dialyzed against the
storage buffer (0.1 mM EDTA and 10% glycerol in 25 mM Tris-HCl, pH 8.0) and
was stored at 80°C for an in vitro assay.
Amino acid speciﬁcity assay of LnmI (A-PCP). Amino acid-dependent ATP-
sodium pyrophosphate (PPi) assays were performed according to procedures in
the literature (14, 28). A typical assay reaction (100 l) contained 100 nM LnmI
(A-PCP), 1 mM ATP, and 0.1 mM PPi with 0.5 Ci of [
32P]PPi (40.02 Ci/mmol;
NEN Life Science Products, Boston, Mass.), 1 mM MgCl2, 0.1 mM EDTA, and
0.5 mM amino acid in 50 mM sodium phosphate buffer, pH 7.8. After 30 min of
incubation at 30°C, the assays were stopped by addition of 0.9 ml of cold 1%
(wt/vol) activated charcoal in 3% (vol/vol) perchloric acid. The precipitates were
collected on glass ﬁber ﬁlters (2.4 cm, G-4; Fisher Scientiﬁc, Pittsburgh, Pa.),
washed successively with 10 ml of 40 mM sodium phosphate buffer, pH 8.0, 10 ml
of water, and 5 ml of ethanol, and dried brieﬂy in air. The ﬁlters were mixed with
7 ml of scintillation ﬂuid (ScintiSafe Gel; Fisher Scientiﬁc) and were counted on
a Tri-Carb 2900TR liquid scintillation counter (Packard Instrument Co., Meri-
den, Conn.) to determine the radioactivity.
In vitro phosphopantetheinylation and aminoacylation of holo-LnmI (A-PCP)
were carried out essentially according to methods from the literature (12, 14, 46).
For in vitro phosphopantetheinylation, a typical assay solution (100 l) consisted
of 3 M LnmI (A-PCP), 1 M Svp (46), 25 M coenzyme A, 10 mM MgCl2, and
5 mM dithiothreitol in 75 mM Tris-HCl buffer, pH 8.0, and the reaction mixture
was incubated at 30°C for 30 min. For in vitro aminoacylation, to the holo-LnmI
(A-PCP) reaction mixture were added 0.1 M L-[
35S]Cys (10
3 Ci/mmol; NEN
Life Science) and 3 mM ATP, and the reaction was continued at 30°C for
additional 30 min. The reaction was ﬁnally stopped by addition of 0.9 ml of cold
7% (vol/vol) trichloroacetic acid. The precipitated proteins were collected by
centrifugation and resolved by SDS-PAGE ona4t o2 0 %gradient gel (Bio-Rad
Laboratories Inc., Richmond, Calif.). To determine the radioactivity incorpo-
rated into the holo-LnmI (A-PCP)–L-[
35S]Cys species, the gel was dried between
two sheets of cellulose membrane (KOH Development Inc., Ann Arbor, Mich.)
and visualized by a PhosphorImager (Molecular Dynamics/Amersham Pharma-
cia Biotech, Piscataway, N.J.).
Nucleotide sequence accession number. The nucleotide sequence reported
here has been deposited in the GenBank database under accession number
AF484556.
RESULTS
Cloning of a thiazole-forming NRPS module from S. atroo-
livaceus S-140 by PCR and mapping of the lnm gene cluster.
Seven conserved motifs for the Cy domain (Cy1 to Cy7) and
two conserved motifs for the Ox domain (Ox1 and Ox2) are
known for thiazole-forming NRPS (Fig. 4). PCR primers for
the Cy and Ox domains were based on the Cy1 (for Cy-FP) and
Cy6 (Cy-RP) motifs and Ox1 (Ox-FP) and Ox2 (Ox-RP) mo-
tifs, respectively. Initial PCR attempts with conventionally de-
signed degenerate primers, taking into the GC bias at the
wobble position for G/C-rich Streptomyces DNA, failed to am-
plify any speciﬁc products. We then adopted the CODEHOP
strategy of PCR primer design (43) and designed the two pairs
of primers as shown in Fig. 2. With S. atroolivaceus S-140
genomic DNA as the template, while products appeared to be
nonspeciﬁc when the Ox-FP and Ox-RP pair of primers was
used, a distinct band with the expected size of 1.1 kb was
readily ampliﬁed with the Cy-FP and Cy-RP pair of primers.
This product was cloned (pBS3001), and 12 randomly selected
clones were subjected to sequencing. Eight yielded an identical
sequence (except differences resulting from primer utilization),
which shows signiﬁcant homology to Cy domains of known
thiazole-forming NRPS (Fig. 4B), and four were nonspeciﬁc
sequences. This PCR-ampliﬁed Cy fragment was then recov-
ered as a 1.1-kb EcoRI fragment from pBS3001 and used as a
probe (Fig. 3A, Probe-1) to screen an S. atroolivaceus genomic
library that was constructed in the Streptomyces-E. coli shuttle
cosmid, pOJ446. Of the 4,000 colonies screened, 12 positive
clones were identiﬁed, 11 of which were conﬁrmed by PCR and
Southern analysis to contain the same fragment hybridizing to
the Cy probe. To ensure that we have a full coverage of the
entire lnm gene cluster, additional chromosomal walking from
this locus was carried out with probe-2, probe-3, and probe-4
(Fig. 3A), eventually leading to the localization of a 172-kb
continuous DNA region covered by overlapping cosmids as
exempliﬁed by pBS3004, pBS3005, pBS3006, pBS3007, and
pBS3008 (Fig. 3A).
To examine if these cosmids also harbor an Ox domain, we
carried out PCRs using the Ox-FP and Ox-RP pair of primers
with the cosmid clone DNA as templates. Among the 11 Cy
domain-containing cosmids tested, 9 yielded a distinct band
with the predicted size of 0.3 kb. This fragment was cloned
(pBS3002) and sequenced, revealing that it is highly homolo-
gous to known Ox domains (Fig. 4C). Finally, to determine if
the ampliﬁed Cy and Ox domains constitute the same thiazole-
forming NRPS module, we carried out additional PCRs using
the Cy-FP and Ox-RP pair of primers with one of the cosmids,
pBS3006, as the template. A distinct band with the predicted
size of 5.2 kb was ampliﬁed and cloned (pBS3003). DNA
sequencing of the cloned fragment revealed that it contained
an additional Cy domain, an A domain, and a PCP domain,
ﬂanked by the Cy and Ox domains that had been ampliﬁed
individually (Fig. 3B). The type of domains and organization
identiﬁed from the PCR product is exactly what would be
predicted for a thiazole-forming NRPS module (11, 27, 44, 51).
Sequence analysis of the lnmI locus. Restriction mapping
and Southern analysis mapped the PCR-ampliﬁed 5.2 kb in
pBS3003 to three overlapping fragments, a 4.6-kb NcoI frag-
ment (pBS3009), a 2.8-kb NcoI fragment (pBS3010), and a
5.1-kb BamHI fragment (pBS3011), from pBS3006. These
three fragments constitute an 11-kb contiguous region. DNA
sequencing of this region (10,881 bp) revealed one completed
open reading frame (ORF), lnmH, and two incomplete ORFs,
lnmG and lnmI, all of which are transcribed in the same direc-
tion (Fig. 3B). The incomplete lnmG gene starts out of the
sequenced region and ends with a TGA codon 1,643 bp into
the sequence. The deduced product of lnmG, the 546-amino
acid C terminus, shows signiﬁcant homology to a class of pu-
tative enoyl reductase domain of PKSs, such as the Orf8 pro-
tein from a Shewanella sp. (GenBank accession number
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ATCC 20888 (GenBank accession number AAK72880) (33).
The Orf8 and OrfB proteins are components of the newly
discovered PKSs involved in the biosynthesis of very-long-
chain polyunsaturated fatty acids. Immediately downstream
(70 bp) of lnmG is the complete ORF, lnmH, which starts with
an ATG codon and ends with a TGA codon. The deduced
product of lnmH consists of 274 amino acids but shows no
signiﬁcant homology to any protein in the databases. Sepa-
rated from lnmH by 132 bp, the other incomplete ORF, lnmI,
FIG. 4. Conserved motifs from LnmI-NRPS module and alignments of the A, Cy, Ox, and PCP domains with known NRPS domains. Protein
accession numbers (GenBank) are given in parentheses: AcvS (B61212), BacA (O68006), BlmIII (AAG02365), BlmIV (AAG02364), EposP
(AAF26925), GrsA (P14687), HMWP2 (P48633), MtaC (AAF19811), MtaD (AAF19812), LnmI-NRPS (AF484556), PchE (AAD55800), TycC
(O30409), and VibF (AAG00566).
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region (10,881 bp).
The sequenced lnmI portion contains all three PCR-ampli-
ﬁed fragments, and the deduced product of lnmI, the 3,623-
amino-acid N terminus, clearly consists of domains character-
istic for both known NRPS and PKSs (6, 7, 13). Located at the
N termini of LnmI is a complete thiazole-forming NRPS mod-
ule composed of two-tandem Cy domains, an A domain, a PCP
domain, and an Ox domain. All the domains contain the
known conserved motifs (12, 27), which is indicative that they
likely are functional (Fig. 4B). It is very unusual to ﬁnd two-
tandem Cy domains in a single NRPS module, but a precedent
has been observed recently in VibF (GenBank accession num-
ber AAG00566) for vibriobactin biosynthesis (31). Using site-
directed and domain-deletion mutagenesis, Marshall and co-
workers mapped the speciﬁc functions of the two-tandem Cy
domains in VibF—the second Cy domain for condensation and
the ﬁrst Cy domain for cyclization and dehydration. The two
Cy domains in LnmI could play a similar role in LNM biosyn-
thesis. The amino acid speciﬁcity of an NRPS module is de-
termined by the A domain, which could be predicted according
to the so-called “speciﬁcity-conferring codes” (8, 47). The
speciﬁcity-conferring codes for the A domain were identiﬁed
as follows: D-235, L-236, F-239, N-278, F-299, S-301, L-322,
V-330, W-331, and K-517, suggesting that LnmI-A speciﬁes for
L-Cys. This is consistent with the fact that the A domain ex-
hibits the highest sequence homology to A domains of NRPS
known to specify for L-Cys (Fig. 4A). The PCP domain is only
modestly conserved at the signature LGGXS motif (Fig. 4D).
In order to be functional, PCP must be posttranslationally
modiﬁed by the covalent attachment of the 4-phospho-
pantetheine group to the Ser residue of this motif (S, under-
lined) (6, 46). The Ox domain has only been found in thiazole-
and oxazole-forming NRPS modules but not in thiazoline- and
oxazoline- or thiazolidine- and oxazolidine-forming NRPS
modules (10, 11, 27, 44). This is consistent with the fact that the
biosynthesis of the latter does not require an oxidation step.
Two locations within an NRPS module have been observed for
the Ox domain (11). The Ox domain could be located between
the A8 and A9 motifs of an A domain, as for EposP (GenBank
accession number AAF26925) and MtaD (GenBank accession
number AAF19812), or could be located downstream of PCP,
as for BlmIII (GenBank accession number AAG02365) and
MtaC (GenBank accession number AAF19811). The Ox do-
main in the LnmI-NRPS module apparently falls into the latter
group, being located downstream of the PCP domain.
Following the NRPS module throughout the rest of the
sequenced LnmI are two tandem KS domains (the second KS
domain is incomplete), indicative of an incomplete PKS mod-
ule. Both KS domains are highly homologous to known KS
domains (6, 7, 48). To our knowledge, tandem KS domains
within a PKS module are unprecedented, although it is not
known if both KS domains are functional. The LnmI-PKS
module would start with a KS domain consisting of 420 amino
acids. This KS domain is characterized by the well-deﬁned
signature TSCSSSFAAL motif, the Cys residue of which (C,
underlined) has been established to be the active site for all
known KS domains (48). Although incomplete (only 78 amino
acids), the sequenced 3 end of lnmI clearly encodes a KS
domain. Hybrid NRPS-PKS has been deﬁned as megasyntheta-
ses that can incorporate biosynthetic building blocks of both
amino acids and short carboxylic acids into the resultant hybrid
peptide-polyketide product—an NRPS-bound growing pepti-
dyl intermediate is further elongated by a PKS module or vice
versa (6, 7, 13). The interacting NRPS and PKS modules could
either be covalently linked with all domains arranged in a
linear order on the same protein, known as type I hybrid, or
could physically reside on separate proteins, known as type II
hybrid (14). Pending the completion of its C terminus, LnmI
would be a hybrid NRPS-PKS megasynthetase with a type I
hybrid architecture.
Development of a genetic system and disruption of the lnmI
gene in S. atroolivaceus. No genetic study of S. atroolivaceus had
been reported prior to our investigation. We set out to estab-
lish a genetic system for this strain in order to conﬁrm that the
cloned gene cluster encodes LNM biosynthesis, setting the
stage for production of novel LNM analogs by manipulating
LNM biosynthesis in vivo. S. atroolivaceus S-140 grows opti-
mally between 28 and 30°C but cannot grow at or beyond 37°C.
Among the 10 media (AS-1, DNB, GMP, ISP-2, ISP-4, R2YE,
SGGP, SR12, TSB, and YEME) (25) tested, TSB medium was
found to be most suitable for vegetative growth of S. atrooli-
vaceus. However, for protoplast preparation and genomic
DNA isolation, it is necessary to supplement TSB with 25 mM
MgCl2 (ﬁnal concentration) to facilitate lysozyme digestion,
whereas supplementing glycine at a concentration as low as
0.1% (wt/vol) has adverse effects on both protoplast prepara-
tion and DNA isolation. S. atroolivaceus S-140 sporulates very
well on ISP-4 agar at 28°C, and the color of spores ranges from
grayish to dark blue, depending on the age of the culture. S.
atroolivaceus S-140 is highly sensitive to both Apr and thio-
strepton (Thi) (complete inhibition of growth at 10 and 3
g/ml, respectively); therefore, 50 g of Apr and 25 go fT h i
per ml were used throughout this study for selection.
Although S. atroolivaceus S-140 can be protoplasted in a
respectable yield (30%), they cannot be regenerated efﬁciently
under all conditions tested. The best regeneration frequency
(0.6%) was obtained when the protoplasts were made from
cells grown in YEME medium and regenerated on R2YE
plates supplemented with 10 mM MgCl2. Due to the low re-
generation frequency, protoplast-mediated transformation for
S. atroolivaceus S-140 was not very successful. With nonrepli-
cative plasmids such as pBS3012, the transformation frequency
was only about 10
9 per g of DNA. In contrast, we were
successful in developing a protocol for conjugation between E.
coli S17-1 and S. atroolivaceus S-140. Following a procedure
taken from the literature (30) with modiﬁcations, we found
that conjugation between E. coli S17-1 and S. atroolivaceus
S-140 occurred with the highest frequency on modiﬁed ISP-4
agar freshly supplemented with 10 mM MgCl2. The exconju-
gant frequencies for replicating plasmids such as pBS3013 were
approximately 10
4 to 10
5 and for nonreplicating plasmids
such as pBS3012 were 10
5 to 10
6.
To conﬁrm that the cloned gene cluster encodes LNM bio-
synthesis, we inactivated lnmI by insertional disruption via a
single-crossover homologous recombination event (Fig. 5).
Construct pBS3012 was selected for this experiment, which
contains an 1.1-kb internal fragment of lnmI. After introduc-
tion of pBS3012 into S. atroolivaceus S-140 by conjugation,
exconjugants that were resistant to Apr were isolated. Since
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mid pOJ260, those exconjugants must have resulted from in-
tegration of pBS3012 into the S. atroolivaceus chromosome by
homologous recombination and were named S. atroolivaceus
SB3001 mutant strains (Fig. 5A).
Characterization of the lnmI-disrupted S. atroolivaceus
SB3001 strain as a non- LNM-producing mutant. To conﬁrm
that lnmI disruption had occurred by a single-crossover homol-
ogous event, Southern analysis of the DNA from three ran-
domly selected isolates of the SB3001 mutant strain was car-
ried out with either pOJ260 or the 1.1-kb internal fragment of
lnmI from pBS3012 as a probe. As shown in Fig. 5B, a distinc-
tive band of the predicted size of 9.2 kb was detected with the
pOJ260 vector as a probe in all three isolates; this band was
absent from the wild-type strain. Complementarily, when the
1.1-kb internal fragment of lnmI was used as a probe, the
4.6-kb band in the wild-type strain was shifted to the 9.2-kb
band in the mutant isolates (Fig. 5C), as would be expected for
disruption of lnmI by a single-crossover homologous recombi-
nation event (Fig. 5A).
FIG. 5. Disruption of lnmI by single-crossover homologous recombination. (A) Restriction maps of the S. atroolivaceus S-140 wild-type and
SB3001 mutant strains showing predicted fragment sizes upon NcoI digestion. Southern analysis of S-140 (lane 1) and SB3001 strain (lanes 2 to
4 for three individual isolates) genomic DNAs digested with NcoI by using the pOJ260 vector (B) and the 1.1-kb lnmI fragment from pBS3012
(C) as a probe, respectively. (D) HPLC analysis with UV detection at 320 nm of partially puriﬁed LNM from the S-140 wild-type and SB3001
mutant strain with authentic LNM standard as a control. LNM, F.
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phologies between the wild-type S-140 and mutant SB3001
strains was observed. S. atroolivaceus fermentation was carried
out according to protocols from the literature (18) with mod-
iﬁcations. The LNM produced was distributed among the my-
celia (15%), broth (5%), and Diaion HP-20 resins
(	80%); therefore, LNM isolation was focused only on the
resins in this study. The isolated yield for LNM from S. atroo-
livaceus S-140 is 3 to 5 mg/liter. The LNM identity was con-
ﬁrmed by coelution with the authentic standard and ESI-MS
analysis. Upon ESI-MS analysis under positive ionization
mode, the puriﬁed product yielded a characteristic (MH)

ion at an m/z of 511, consistent with the molecular formula of
C22H26N2O6S3 for LNM (calculated molecular weight, 510).
LNM production was completely abolished in all three isolates
of the lnmI mutant strain of S. atroolivaceus SB3001, conﬁrm-
ing that lnmI and therefore the cloned lnm gene cluster encode
LNM biosynthesis (Fig. 5D).
Speciﬁc incorporation of L-Cys by the LnmI NRPS module.
To verify the sequence-based prediction that the LnmI NRPS
module speciﬁes for L-Cys, we overexpressed lnmI (A-PCP) in
E. coli and puriﬁed the resultant LnmI (A-PCP) as a fusion
protein with the His8 tag at the C terminus (Fig. 6A). By
variation of the expression conditions, lnmI (A-PCP) was very
well expressed, resulting in the production of a signiﬁcant
quantity of pure protein (92 mg/liter). After SDS-PAGE, LnmI
(A-PCP) migrates with an Mr of 73 kDa, consistent with the
calculated Mr of 73,231 Da. The puriﬁed LnmI (A-PCP) pro-
tein was active as measured by the amino acid-dependent
ATP-PPi exchange assay. Among the 22 amino acids tested,
LnmI (A-PCP) speciﬁcally activates L-Cys, an amino acid that
would be required for the biosynthesis of the thiazole moiety of
LNM (Fig. 6B). The fact that the L-Cys-speciﬁc, thiazole-form-
ing LnmI NRPS module is followed by a PKS module would
agree well with the hybrid peptide-polyketide hypothesis for
LNM biosynthesis.
To conﬁrm that the activated L-Cys could be loaded to the
PCP domain of LnmI, we carried out the in vitro aminoacyla-
tion of LnmI (A-PCP). Since PCPs heterologously overpro-
duced in E. coli are often in the apo-form or only partially
modiﬁed into the holo-form (46) (these PCPs are poor sub-
strates for the endogenous E. coli phosphopantetheinyl trans-
FIG. 6. (A) Expression and puriﬁcation of LnmI (A-PCP) as analyzed by electrophoresis on an SDS–12% polyacrylamide gel (the calculated
molecular weight for LnmI [A-PCP] is 73.231 kDa). Lane 1, molecular weight markers; lane 2, total protein before IPTG induction; lane 3, total
protein after IPTG induction; lane 4, total soluble proteins; and lane 5, puriﬁed LnmI (A-PCP). (B) Amino acid substrate speciﬁcity as determined
by the ATP-PPi exchange assay (100% relative activity corresponds to 8  10
5 cpm). In vitro aminoacylation of holo-LnmI (A-PCP) with L-[
35S]Cys
as a substrate was performed; results of SDS-polyacrylamide gel analysis ona4t o2 0 %gradient gel (C) and phosphorimaging (D) are shown. Lane
1, molecular weight markers; lane 2, complete assay with no ATP; lane 3, complete assay with no Svp; and lane 4, complete assay.
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pantetheinylation of the puriﬁed LnmI (A-PCP) to ensure that
it is fully in the holo form. We chose the Svp PPTase for its
broad carrier protein speciﬁcity (46). In vitro aminoacylation
was then carried out by incubating the holo-LnmI (A-PCP) in
the presence of L-[
35S]Cys and ATP and was visualized by
phosphorimaging. As shown in Fig. 6C and D, aminoacylation
of LnmI (A-PCP) is very efﬁcient and speciﬁc. Removal of
either ATP (lane 2) or the Svp PPTase (lane 3) from the
complete assay solution completely abolished or signiﬁcantly
reduced L-Cys labeling of LnmI (A-PCP).
DISCUSSION
Methods for PCR cloning of both NRPS and PKS genes
have been reported, relying on the amino acid sequence con-
servation of the A domain in NRPS (50) and the KS domain in
PKSs (32, 37), respectively. While very effective, these methods
suffer from the multiple nonribosomal peptide or polyketide
pathways commonly existing in the genome of a given micro-
organism, especially in the Streptomyces species (2, 38). The
ampliﬁed A or KS fragments often represent a pool of heter-
ologous products from different nonribosomal peptide or poly-
ketide biosynthetic gene clusters. To determine which PCR
product and subsequently which gene cluster are the desired
ones requires unambiguous genetic, biochemical, or chemical
evidence. If a genetic system is available to the given strain, it
is possible but still time consuming to test individual PCR
products by a series of gene inactivation experiments. How-
ever, most strains were discovered by their ability to produce a
biologically active metabolite and are, therefore, poorly char-
acterized physiologically and genetically. Thus, an amenable
genetic system is often not available, which presents a serious
challenge for deciding which gene cluster is to be further pur-
sued.
We recognized, on the basis of its structural features, that
LNM is a hybrid peptide-polyketide macrolactam containing a
thiazole moiety. Taking advantage of the emerging paradigm
for NRPS-templated thiazole biosynthesis, we reasoned that
the choice of amplifying a Cy and/or Ox domain of a thiazole-
forming NRPS module rather than the KS domain of a PKS
module or A domain of an NRPS module as a probe would
greatly increase our chances of speciﬁcally isolating the lnm
biosynthetic gene cluster. Realizing that the amino acid se-
quence conservations among the known Cy and Ox domains
are limited to a few very short core motifs, we adopted the
CODEHOP strategy of PCR primer design, which allowed us
to design hybrid primers consisting of a short 3degenerate
core region (for selectivity) and a longer 5consensus clamp
region (for speciﬁcity) (Fig. 2) (43). We successfully ampliﬁed
a Cy domain from the S. atroolivaceus S-140 genome, and, with
it as a probe, subsequently cloned a thiazole-forming NRPS
module, thereby localizing the lnm biosynthetic gene cluster.
The involvement of the cloned DNA in LNM biosynthesis has
been unambiguously established by insertional inactivation of
the lnmI gene (Fig. 5) and biochemical characterization of the
LnmI protein (Fig. 6). Although we were unable to amplify the
Ox domain directly from the S. atroolivaceus genome, we were
successful in amplifying the Ox domain from cosmid DNA,
validating the usefulness of these primers. The latter should
not come as a surprise, retrospectively, because the Ox1 and
Ox2 motifs of the LnmI-Ox domain are less conserved than
those used to design the Ox-FP and Ox-RP primers (Fig. 4C).
It should be pointed out that, while the PCR products appear
to be very speciﬁc in this study, this approach could not dis-
criminate among different heterocycle-forming NRPS genes if
the organism produces multiple heterocycle-containing metab-
olites. Using this PCR cloning strategy, we recently ampliﬁed a
thiazoline-forming NRPS module and a thiazole-forming
NRPS module from Streptomyces ﬂavoviridis ATCC 21892 that
produces the antitumor antibiotic phleomycin (Fig. 1) and
mapped them to the phleomycin biosynthetic gene cluster (Y.
Fan and B. Shen, unpublished data). This method should now
be taken into consideration in formulating a strategy for clon-
ing biosynthesis gene clusters of other heterocycle-containing
natural products.
On the basis of the hybrid NRPS-PKS paradigm, we could
propose the following model for the early steps of LNM bio-
synthesis involving two NRPS modules. A yet-to-be-identiﬁed
loading NRPS module, consisting of at least A and PCP do-
mains, would initiate LNM biosynthesis by selecting, activat-
ing, and loading a D-alanine (Ala) to its PCP. (It cannot be
predicted a priori if D-Ala is incorporated directly or derived
from L-Ala via an epimerization step. The latter process would
require an epimerization domain within the loading NRPS
module [27, 51].) The NRPS module, residing at the N termi-
nus of LnmI reported in this study, would represent the second
NRPS module that would select, activate, and load a Cys to its
PCP. Condensation between the aligned D-Ala–S-PCP and
Cys–S-PCP and subsequent Cy and Ox would furnish the thia-
zole moiety for LNM biosynthesis. The characteristic Cy-Cy-
A-PCP-Ox domain organization of the LnmI NRPS module
agrees well with the enzyme functions that would be required
for the biosynthesis of the thiazole moiety of LNM according
to the proposed mechanism. The amino acid speciﬁcity of the
LnmI NRPS module has been conﬁrmed biochemically in vitro
to be L-Cys, providing direct evidence for the proposed path-
way. Thus, in a mechanistic analogy to VibF (31), we propose
that the second Cy domain is responsible for the condensation
step, yielding the dipeptidyl–S-PCP intermediate that is subse-
quently cyclized by the ﬁrst Cy domain to afford the thiazoli-
nyl–S-PCP intermediate. The latter is ﬁnally oxidized by the Ox
domain to yield the thiazonyl–S-PCP species. At this point, the
growing peptidyl–S-PCP intermediate is switched to the PKS
machinery. Further elongations of thiazonyl–S-PCP by PKS
modules complete the biosynthesis of the LNM hybrid pep-
tide-polyketide carbon backbone. The identiﬁcation of the in-
complete PKS module residing immediately after the NRPS
module on LnmI supports the hybrid NRPS-PKS hypothesis
for LNM biosynthesis.
Since we have identiﬁed overlapping cosmids that cover a
total of 172 kb of the DNA region (Fig. 3), we believe that we
have localized the entire lnm gene cluster. In addition to the
two NRPS modules, at least six PKS modules would be needed
for the incorporation of the six C-2 units from malonyl coen-
zyme A to form the LNM macrolactam structure. Although we
cannot predict a priori the biosynthetic origin of the 1,3-dioxo-
1,2-dithiolane moiety due to its unprecedented structural fea-
tures, genetic analysis of the complete lnm gene cluster could
shed light on its biosynthesis. The localization of the lnm gene
7022 CHENG ET AL. J. BACTERIOL.cluster, the conﬁrmation of the LNM biosynthesis by a hybrid
NRPS-PKS megasynthetase, and development of an efﬁcient
genetic system for in vivo manipulation of LNM biosynthesis in
S. atroolivaceus have now set up an excellent stage for future
investigations of LNM biosynthesis. Given LNM’s potent an-
titumor activity, in particularly against tumors that are resistant
to clinically important anticancer drugs, we envisage applying
the methodologies of combinatorial biosynthesis to LNM for
the production of novel analogs, some of which could lead to
the discovery of novel anticancer drugs.
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